Decision Resources Group is dedicated to helping life sciences companies make a positive impact for patients around the world through expert consultation, proprietary data and research, and technology solutions. Every client is a partner to us, and we work hard to help them drive better outcomes, and maximum return on their commercial investments.
Syneos Health™ (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visitSyneosHealth.com.
Aetion delivers real-world evidence for the manufacturers, purchasers, and regulators of medical treatments and technologies. The Aetion Evidence Platform® analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on safety, effectiveness, and value. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions—what works best, for whom, and when—to guide product development, commercialization, and payment innovation.
COTA was founded in 2011 by doctors, engineers, and data scientists to create clarity from fragmented and often-inaccessible real-world data. By using our proprietary technology, advanced analytics and deep expertise to organize complex data, we provide a comprehensive picture of cancer that can be used to advance care and research. We believe that everyone touched by cancer deserves a clear path to care. Together, we can make that vision a reality.
Adelphi Real World: Experts in generating real-world data and shaping real-world evidence
Conducting multi-country real-world observational studies for over 25 years, grounded in extensive heritage of Adelphi’s Disease Specific Programmes™, supported by the expansion of our real-world evidence services to meet pharmaceutical client needs.
We provide a unique range of real-world data involving physicians, patients, and caregivers; achieved through our market-leading Disease Specific Programmes™, tailored non-interventional studies, international secondary database analyses and evidence landscaping.
Founded in 2008, Life Image has spent the past 11 years building an interoperable network connecting entities across the entire healthcare ecosystem. It connects over 10,000 U.S. facilities, with 150,000 U.S. providers and 58,000 clinics globally. The network enables access to the accurate, real-time, robust data sets that allow stakeholders to make care decisions based on a single version of the truth, fostering better outcomes while ensuring stakeholders are engaged and satisfied with the healthcare experience.
Boston Health Economics (BHE) brings healthcare analytics within reach. With over two decades of experience, BHE provides novel solutions to allow more than 25 of the world’s largest life science companies, health plans and provider groups to better understand the clinical outcomes and value of various patient care strategies. BHE’s market-leading platform transforms the way analysts from diverse disciplines answer complex and critical questions and make insightful predictions. Analyses executed on the platform have been used in numerous regulatory and reimbursement agency submissions in the US, EU, Russia, China and Australia and more than 110 manuscripts and abstracts. Managing big data, getting results faster, and answering critical business questions has never been easier.
Concerto HealthAI, a SymphonyAI portfolio company, is a next generation Real World Evidence company that partners with the American Society of Clinical Oncology’s CancerLinQ initiative and healthcare providers across the U.S. Concerto HealthAI develops engineered Real-World Data products designed for specific use cases, including post approval studies leading to label modifications and market access initiatives and regulatory submissions. Concerto HealthAI’s engineered datasets are deployed in a clinical cloud environment, with AI metadata, AI Models and AI-enabled applications all aligned to generate “precision evidence” required for high priority use cases.
Komodo Health believes that smarter, more innovative use of data and analytics is essential for reducing disease burden. We apply advanced data science techniques to our first-of-its-kind Healthcare Map™, which tracks the unique patient journeys of 330 million patients. Using our cloud-based platform and application suite, we empower a multitude of healthcare stakeholders – life science companies, healthcare payers and providers, patient advocacy groups, and others – to create a more cost-effective, value-driven healthcare system.
Indegene is a healthcare solutions company that helps drive effectiveness and efficiency while bringing pharma products to market through modern commercial and medical operations by combining deep medical understanding, artificial intelligence, and flexible engagement models.
Imagia brings together healthcare expertise and advanced artificial intelligence to diagnose, treat, and cure high burden diseases. Through its EVIDENS platform, Imagia enables its stakeholders to learn from distributed healthcare data and discover AI-driven clinical solutions. Working collaboratively with hospital, biotech, pharma, and medical device partners, Imagia is on a mission to unleash the potential of all data across all organizations to achieve medical breakthroughs.
DXC’s digital technologies give life sciences organizations the tools they need to accelerate innovation and reduce time-to-market for new therapies, devices and medicines. DXC’s proven expertise helps clients improve business agility and operational efficiency.
PicnicHealth provides researchers with the most complete patient-level real-world data (RWD). In the U.S., an individual's medical records are fragmented across numerous sources and formats. PicnicHealth’s unique methodology of collecting records on behalf of consenting patients allows researchers to get the full picture of patients’ experiences across all sites of care. Consenting patients’ data is de-identified, aggregated, and abstracted in a customized manner to answer your priority research questions. PicnicHealth works with researchers across the life sciences, including top biopharma, to advance the development of treatments for better patient outcomes.